These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 19034346

  • 1. Concurrent cisplatin/radiation followed by adjuvant cisplatin/paclitaxel in treatment of patients with stage IB grade 3, IC and IIA endometrial carcinoma.
    Foad I, Sharawy I, Mostafa E, Margergis M, Hussein T.
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):163-9. PubMed ID: 19034346
    [Abstract] [Full Text] [Related]

  • 2. Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study.
    Frigerio L, Mangili G, Aletti G, Carnelli M, Garavaglia E, Beatrice S, Ferrari A.
    Gynecol Oncol; 2001 Apr; 81(1):53-7. PubMed ID: 11277649
    [Abstract] [Full Text] [Related]

  • 3. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T, Radiation Therapy Oncology Group.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):168-73. PubMed ID: 15093913
    [Abstract] [Full Text] [Related]

  • 4. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
    Milgrom SA, Kollmeier MA, Abu-Rustum NR, Tew WP, Sonoda Y, Barakat RR, Alektiar KM.
    Gynecol Oncol; 2013 Sep 01; 130(3):436-40. PubMed ID: 23800696
    [Abstract] [Full Text] [Related]

  • 5. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation.
    Dueñas-Gonzalez A, López-Graniel C, González-Enciso A, Cetina L, Rivera L, Mariscal I, Montalvo G, Gómez E, de la Garza J, Chanona G, Mohar A.
    Ann Oncol; 2003 Aug 01; 14(8):1278-84. PubMed ID: 12881393
    [Abstract] [Full Text] [Related]

  • 6. Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.
    Mundt AJ, McBride R, Rotmensch J, Waggoner SE, Yamada SD, Connell PP.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1145-53. PubMed ID: 11483323
    [Abstract] [Full Text] [Related]

  • 7. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
    Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ.
    Gynecol Oncol; 2009 Oct 01; 115(1):6-11. PubMed ID: 19632709
    [Abstract] [Full Text] [Related]

  • 8. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T.
    Gynecol Oncol; 2006 Oct 01; 103(1):155-9. PubMed ID: 16545437
    [Abstract] [Full Text] [Related]

  • 9. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
    Mundt AJ, Murphy KT, Rotmensch J, Waggoner SE, Yamada SD, Connell PP.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1154-60. PubMed ID: 11483324
    [Abstract] [Full Text] [Related]

  • 10. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium.
    Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW.
    Gynecol Oncol; 2013 May 01; 129(2):304-9. PubMed ID: 23385150
    [Abstract] [Full Text] [Related]

  • 11. Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.
    Mostafa E, Nasar MN, Rabie NA, Ibrahim SA, Barakat HM, Rabie AN.
    J Egypt Natl Canc Inst; 2006 Dec 01; 18(4):348-56. PubMed ID: 18301458
    [Abstract] [Full Text] [Related]

  • 12. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT, Rotmensch J, Yamada SD, Mundt AJ.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1272-6. PubMed ID: 12654437
    [Abstract] [Full Text] [Related]

  • 13. NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer.
    Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W, Gaffney DK.
    Cancer; 2015 Jul 01; 121(13):2156-63. PubMed ID: 25847373
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
    Kiess AP, Damast S, Makker V, Kollmeier MA, Gardner GJ, Aghajanian C, Abu-Rustum NR, Barakat RR, Alektiar KM.
    Gynecol Oncol; 2012 Nov 01; 127(2):321-5. PubMed ID: 22850412
    [Abstract] [Full Text] [Related]

  • 17. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
    Liang LW, Perez AR, Cangemi NA, Zhou Q, Iasonos A, Abu-Rustum N, Alektiar KM, Makker V.
    Int J Gynecol Cancer; 2016 Mar 01; 26(3):497-504. PubMed ID: 26825840
    [Abstract] [Full Text] [Related]

  • 18. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J.
    Int J Gynecol Cancer; 2010 Aug 01; 20(6):1000-5. PubMed ID: 20683408
    [Abstract] [Full Text] [Related]

  • 19. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Mehta N, Yamada SD, Rotmensch J, Mundt AJ.
    Int J Radiat Oncol Biol Phys; 2003 Nov 15; 57(4):1004-9. PubMed ID: 14575831
    [Abstract] [Full Text] [Related]

  • 20. The Clinical Features of Recurrent Endometrial Cancer in Japan: Chemotherapy Instead of Radiotherapy as Postoperative Adjuvant Treatment.
    Iwase H, Furukawa S, Hirasawa T, Asai S, Ohara T, Hosonuma S, Endo S, Tazo Y, Sato H, Takada T, Arai M, Ikeda M, Shida M, Yoshioka N, Tozawa-Ono A, Suzuki N, Mikami M, Onda T.
    Int J Gynecol Cancer; 2018 Oct 15; 28(8):1616-1623. PubMed ID: 30095709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.